High expressed-EZH2 cases more frequently had an advanced clinical stage (lymph node metastasis) and aggressive features than EZH2-low cases, potentially indicating the high risk of HER2-positive BC (p < 0.05). The gene discussed is EZH2; the disease is metastatic malignant neoplasm in the lymph nodes.